Login / Signup

Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.

Mattia BertonSara BettonteFelix StaderManuel BattegayCatia Marzolini
Published in: Open forum infectious diseases (2023)
.
Keyphrases
  • metabolic syndrome
  • insulin resistance
  • mycobacterium tuberculosis
  • type diabetes
  • weight loss
  • weight gain
  • high fat diet induced
  • body mass index
  • physical activity